secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoHealth, Inc. (GOCO)
CIK:        0001808220
Form:       8-K/A
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001808220-24-000016
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoHealth reports Q4 net loss down 98.5% to $2.3M; FY 2023 Adj. EBITDA $75.1M
----------------------------------------------------------------------------

- Q4 net revenues $276.7M vs $69.4M YoY; FY net rev $734.7M vs $631.7M.
- Q4 net loss $2.3M vs $149.2M loss YoY; FY net loss $151.3M vs $376.3M loss YoY.
- Q4 Adjusted EBITDA $57.0M (up 160.1% YoY); FY Adj. EBITDA $75.1M (up 157.9% YoY).
- Cash flow from operations $109.1M in 2023, up 79.2% from $60.9M in 2022.
- Non-agency sales 60% of Q4 Medicare revenue vs 26% in 2022; no Lookback adjustment in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808220/000180822024000016/0001808220-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808220/000180822024000016/goco-20240314.htm
  HTML page:      https://secwatch.observer/filing/0001808220-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer